HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sulfapyridine

HCID 5336
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
144-83-2
Standard SMILES
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1
InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N
Molecular formula
C11H11N3O2S
Average molar mass
249.29 g/mol
Monoisotopic mass
249.05719778

Overview

Sulfapyridine appears as odorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral. (NTP, 1992)

Names & identifiers

Preferred name
Sulfapyridine
IUPAC
4-amino-N-pyridin-2-ylbenzenesulfonamide
English name
Sulfapyridine
Molecular formula
C11H11N3O2S
Molecular weight
249.29

Names & synonyms

sulfapyridine144-83-2Sulphapyridine2-Sulfapyridine2-SulfanilamidopyridinePiridazolSulfidineDagenanSulfidinStreptosilpyridineCoccoclasePlurazol
Show more names
SulfapyridinTHAP114-AMINO-N-[2-PYRIDYL]BENZENE SULFONAMIDE2-hydroxybenzenecarboxylic acid (salicylic acid)RoninA-499m+b693TrianonAdiplon
PyriamidPyridazolEubasin2-SulfanilylaminopyridineEubasinumRelbapiridinaSeptipulmonThioseptal

Database identifiers

CAS
144-83-2
PubChem CID
5336
DTXSID
DTXSID3026067
ChEMBL
CHEMBL700
ChEBI
CHEBI:132842
UNII
Y5V2N1KE8U
EC Number
205-642-7
Nikkaji
J5.831I

Properties

Computed structural propertiesFilling in

XLogP
0
Topological polar surface area
93.5 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
3
Heavy atoms
17
Formal charge
0
Complexity
331

Experimental & physicochemical properties

Drugs · 5 items

Pharmaceuticals -> Metabolite of Sulfasalazine

Pharmaceuticals -> Antibiotics (Sulfonamide)

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

SpringerMaterials PropertiesFusion temperature
LogP · 2 items

0.9

0.35

Solubility · 3 items

less than 1 mg/mL at 72 °F (NTP, 1992)

2.35e-01 g/L

33.1 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Melting Point · 2 items

376 to 379 °F (NTP, 1992)

192 °C

Physical Description

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 12% (6 of 50) of reports.

Danger

H300 (72%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P270, P272, P273, P280, P301+P316, P302+P352, P308+P316, P318, P321, P330, P333+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

REACH registered substance: Sulfapyridine (EC: 205-642-7)

Sulfapyridine: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - Benzenesulfonamide, 4-amino-N-2-pyridinyl-: Human health tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 item

SYMPTOMS: Symptoms of exposure to this compound include fever, rash, agranulocytosis, deposition of crystals in the urinary tract with consequent hematuria or anuria, nausea, vomiting, cyanosis, sensitization and, rarely, granulocytopenia. Other symptoms include acute transient myopia, conjunctivitis, keratitis, disturbances of the optic nerve and retina, temporary impairment of depth perception, swelling of the eyelids, photophobia, lacrimation, Stevens-Johnson syndrome, Lyell syndrome, amblyopia, central scotoma and optic neuritis, usually with papilledema. It can induce crystalluria.

Chemistry & industry

Pharmacology

ATC Code · 2 items

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein BindingApproximately 50% bound to plasma proteins.
Pharmacodynamics · 1 item

Sulfapyridine is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of <i>p</i>-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

Mechanism of Action · 1 item

Sulfapyridine is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid by means of processing the substrate para-aminobenzoic acid (PABA). Dihydropteroate synthetase activity is vital in the synthesis of folate, and folate is required for cells to make nucleic acids, such as DNA or RNA. So if DNA molecules cannot be built, the cell cannot divide.

Biological Half-Life6-14 hours.
Metabolism/Metabolites · 2 items

Hepatic.

Sulfapyridine has known human metabolites that include Sulfapyridine, N-acetyl.

MeSH Pharmacological Classification · 2 items

Related reactions

9 records
New reaction record
HRID 122078 reaction equation
HRID 122078As reactant
HRID 214740 reaction equation
HRID 214740As reactant
HRID 840816 reaction equation
HRID 840816As reactant
HRID 1248965 reaction equation
HRID 1248965As reactant
HRID 1263962 reaction equation
HRID 1263962As reactant
HRID 1391491 reaction equation
HRID 1391491As reactant
HRID 1639484 reaction equation
HRID 1639484As product
HRID 1790179 reaction equation
HRID 1790179As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
· 2 items

Sulfapyridine appears as odorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral. (NTP, 1992)

Solid

Dissociation Constants8.43
Collision Cross Section · 6 items

150.94 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

142.3 Ų [M+H]+ [CCS Type: TW]

150.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

163.9 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

151.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

156.54 Ų [M-H]-

Physicochemical properties

Melting point
191 · 191-193°C
Boiling point
473.5 · 473.5±51.0 °C(Predicted)
Density
1.322 · 1.3220 (rough estimate)
refractive index
1.674 · 1.6740 (estimate)
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
solubility
DMSO (Slightly), Methanol (Slightly)
pka
8.48 · pKa 8.48(H2O t = 25 I = 0.05) (Uncertain)
form
Solid
color
White to Off-White
Water Solubility
0.1 g/100 · <0.1 g/100 mL at 22 ºC
Merck
14 · 14,8938
BRN
222065 · 222065
Stability
Stable. Combustible. Protect from light. Incompatible with strong oxidizing agents.
Major Application
forensics and toxicologypharmaceutical (small molecule)
InChI
1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N
SMILES
Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
CAS DataBase Reference
144 · 144-83-2(CAS DataBase Reference)
FDA UNII
5 V2N1KE8U · Y5V2N1KE8U
NIST Chemistry Reference
Sulfapyridine(144-83-2)
ATC code
1 EB04 · J01EB04
EPA Substance Registry System
Sulfapyridine (144-83-2)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
8 · GHS08
Signal word
Warning
Hazard statements
361 fd · H361fd
Precautionary statements
201 · P201-P202-P280-P308+P313-P405-P501
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
22 · 22-24/25-36-26
WGK Germany
2 · 2
RTECS
9625000 · DA9625000
TSCA
TSCA listed
HazardClass
IRRITANT
HS Code
29350010 · 29350010
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 · Repr. 2
Toxicity
50 orally · LD50 orally in mice: 7.5 mg/g (Wien)
REACH Registrations
Active
Reactive GroupAmines, Phosphines, and Pyridines
Reactivity ProfileSULFAPYRIDINE is an amino acid. Slowly darkens on exposure to light (NTP, 1992). Soluble in both acidic and basic aqueous solutions
Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesAcute Tox. 2 (72%)

Safety & protection

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If a spill of this chemical occurs, FIRST REMOVE ALL SOURCES OF IGNITION, then you should dampen the solid spill material with acetone and transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Safety data

wgk
2
tsca
TSCA listed
rtecs
DA9625000
hs_code
29350010
Toxicity
LD50 orally in mice: 7.5 mg/g (Wien)
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS08
hazard_code
Xi
safety_code
22-24/25-36-26
hazard_class
IRRITANT
Storage Class
11 - Combustible Solids
Hazard statements
H361fd
REACH Registrations
Active
Hazard Classifications
Repr. 2
Precautionary statements
P201-P202-P280-P308+P313-P405-P501

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Drugs used to treat or prevent skin disorders or for the routine care of skin.

Absorption, Distribution and ExcretionApproximately 60-80%
Cellular LocationsMembrane

Uses & manufacturing

UsesUse (kg) in Switzerland (2009): >1000
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing InformationBenzenesulfonamide, 4-amino-N-2-pyridinyl-: ACTIVE
Applications · 5 items

DescriptionSulfapyridine is a sulfonamide antibiotic with antibacterial and anti-inflammatory activities. It is also a metabolite of sulfasalazine formed through bacterial conversion in the colon. It is active against strains of Y. enterocolitica and Salmonella (MICs = 3.1-25 and 25-100 μg/ml, respectively), as well as S. aureus (MBC = 0.8 μM). It is an inhibitor of recombinant P. carinii dihydropteroate synthetase (DHPS; IC50 = 0.18 μM). Sulfapyridine scavenges peroxyl radicals in an oxygen radical absorbance capacity (ORAC) assay. It inhibits histamine release induced by compound 48/80 from isolated rat peritoneal mast cells in a dose-dependent manner. Sulfapyridine (1 μg/kg) also inhibits compound 48/80-induced systemic allergic reaction in rats. Formulations containing sulfapyridine have previously been used in the treatment of dermatological conditions and ulcerative colitis.

UsesUsed in treatment of dermatitis herpetiformis; antibacterial.

Usesantibacterial, dermatitis herpetiformis therapy

General DescriptionSulfapyridine’s plasma half-life is 9 hours.This compound is a white, crystalline, odorless, and tastelesssubstance. It is stable in air but slowly darkens on exposureto light. It is soluble in water (1:3,500), in alcohol(1:440), and in acetone (1:65) at 25°C. It is freely soluble indilute mineral acids and aqueous solutions of sodium andpotassium hydroxide. The pKa is 8.4. Its outstanding effectin curing pneumonia was first recognized by Whitby; however,because of its relatively high toxicity, it has been supplantedlargely by sulfadiazine and sulfamerazine. Severalcases of kidney damage have resulted from acetylsulfapyridinecrystals deposited in the kidneys. It also causes severenausea in most patients. Because of its toxicity, it is usedonly for dermatitis herpetiformis.Sulfapyridine was the first drug to have an outstandingcurative action on pneumonia. It gave impetus to the studyof the whole class of N1 heterocyclically substituted derivativesof sulfanilamide.

General DescriptionOdorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral.

Upstream & downstream products

Upstream raw materials

2-Aminopyridine4-Nitro-N-2-pyridinyl-benzenesulphonamideDiazene, 1,2-diphenyl-, stereoisomer4-Chloro-N-(pyridin-2-yl)benzenesulfonamide4'-(2-pyridylsulphamoyl)acetanilideSulfanilyl fluorideN-Acetylsulfanilyl chlorideAcetanilideSulfanilamide

Downstream products

Sulfasalazine

Additional notes

DefinitionChEBI: A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.